David Goldberger brings over 40 years of pharmacy practice and pharmaceutical industry experience. He has most recently been with Otsuka Pharmaceuticals Research and Development (Otsuka) as Vice President of Global Regulatory Affairs in the U.S. and Europe. At Otsuka, he led the Regulatory Affairs efforts to gain approval for multiple CNS products, including Abilify Maintena and Rexulti, new indications for Abilify, and other product and therapeutic area approvals. Before Otsuka, he held senior-level positions in Global Regulatory Affairs for Johnson and Johnson (J&J) Pharmaceutical Research and Development in Global Regulatory Affairs. Throughout his career, he has covered the full range of investigational product development and marketed products across multiple therapeutic areas, including psychiatry and neurology. Mr. Goldberger has extensive experience working with the U.S. FDA, EMA, Health Canada, and other global health authorities. In addition, he led CMC Regulatory Affairs, Labeling, Regulatory Operations/Technology, and Medical Writing areas. Mr. Goldberger holds bachelor’s and master’s degrees from Rutgers University.